Related Experiment Video
Updated: Jun 25, 2026

03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000-2004
Michelle M Kim1, Janis E Blair, Elizabeth J Carey
1Mayo Clinic, Scottsdale, Arizona 85259, USA.
Emerging Infectious Diseases
|February 26, 2009
Summary
Coccidioidomycosis is a common cause of community-acquired pneumonia (CAP) in endemic areas. Diagnosis requires specific laboratory testing, as clinical features are not reliable predictors of this fungal infection.
Area of Science:
- Infectious Diseases
- Mycology
- Pulmonology
Background:
- Community-acquired pneumonia (CAP) poses a significant health risk.
- Coccidioidomycosis, caused by Coccidioides species, is an endemic cause of CAP in certain regions.
- The precise frequency of coccidioidomycosis as a cause of CAP remains understudied.
Purpose of the Study:
- To determine the frequency of coccidioidomycosis among patients diagnosed with CAP.
- To investigate potential clinical or demographic predictors of coccidioidomycosis in CAP patients.
Main Methods:
- Prospective evaluation of 59 patients with CAP in the Phoenix, Arizona area.
- Paired serologic testing for coccidioidomycosis was performed on 35 patients.
- Analysis of demographic features, medical history, exposure, and initial diagnostic findings.
Main Results:
- Six out of 35 patients (17%) with CAP showed evidence of acute coccidioidomycosis.
- Rash was more common in patients with coccidioidal pneumonia compared to non-coccidioidal CAP.
- No reliable risk factors or predictors (demographics, comorbidities, exposures, initial labs, or radiography) were identified.
Conclusions:
- Coccidioidomycosis is a frequent cause of CAP in the studied endemic population.
- Distinguishing coccidioidal pneumonia from other CAP etiologies relies heavily on appropriate laboratory diagnostics.
- Clinical presentation alone is insufficient for diagnosing coccidioidal pneumonia.
Related Concept Videos
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: